Rimmer, Emily; Kumar, Anand; Doucette, Steve; Marshall, John; Dial, Sandra; Gurka, David; Dellinger, R. Phillip; Sharma, Satendra; Penner, Charles; Kramer, Andreas; Wood, Kenneth; Ronald, John; Kumar, Aseem; Turgeon, Alexis F.; Houston, Donald S.; Zarychanski, Ryan; The Co-operative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group; Critical Care Medicine. 40(11):2974-2981, November 2012.
Background: Septic shock is a highly inflammatory and procoagulant state associated with significant mortality. In a single randomized controlled trial, recombinant human activated protein C (drotrecogin alfa) reduced mortality in patients with severe sepsis at high risk of death. Further clinical trials, including a recently completed trial in patients with septic shock, failed to reproduce these results.
Read more ...